03:14 AM EDT, 09/12/2024 (MT Newswires) -- Mark E Saad, Director, on September 11, 2024, sold 11,016 shares in Axsome Therapeutics ( AXSM ) for $1,005,871. Following the Form 4 filing with the SEC, Saad has control over a total of 10,302 shares of the company, with 10,002 shares held directly and 300 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1579428/000095017024105616/xslF345X05/ownership.xml